The Plan involves the wind-down of the Company’s REVworx co-manufacturing operations, reflecting EnWave’s Radiant Energy Vacuum (“REV”) technology reaching a more mature stage of commercial adoption which has reduced the need for internal co-manufacturing activities to support customer testing and validation, which is expected to unlock:

1. $1M of Annual Cost Savings: Total reductions in facility leases, labour, and other operating costs are expected to lower EnWave’s annual operating expense base by approximately $1M on a run-rate basis by fiscal 2028 with gradual realizations expected throughout fiscal 2027;

2. Material Net Income Improvements: Anticipated savings are expected to reduce EnWave’s annual operating cost base to approximately $3.7M, contributing incremental net income gradually during fiscal 2027, reaching at least $1M annually starting in fiscal 2028;

3. $2M of Equipment for Monetization: Property, plant, and equipment currently dedicated to REVworx, including a 10kW and 60kW REV machine, has an estimated resale value of $2M and can be transferred to inventory to support future machine sales;

4. Streamlined Business Focus: The Plan reinforces EnWave’s focus on growing its royalty portfolio generated from its installed base of REV machines, while leveraging the technology’s increasing commercial validation and EnWave’s established capabilities and customer relationships to support partners’ product innovation efforts.

The cost savings are expected to be realized gradually throughout fiscal 2027 with the newly released equipment being available for sale almost immediately to service customer demand.

The Plan preserves the Company’s core innovation, engineering, and commercialization capabilities while reflecting EnWave’s continued focus on improving operating leverage, establishing sustainable profitability, and concentrating resources on the highest-value components of its business model, including the generation of recurring royalties from its global portfolio of licensed partners and the sale of REV equipment.

Wind-Down of REVworx Co-Manufacturing Operations

REVworx was originally established to help accelerate the commercialization of new REV-dried products by providing prospective and existing customers with access to commercial-scale production capacity. While REVworx has provided strategic value in demonstrating REV at commercial scale and accelerating the commercial validation of REV^TM technology, EnWave’s growing global ecosystem of licensed royalty partners now provides alternative commercial-scale manufacturing capacity for companies seeking access to REV technology.

Therefore, EnWave has decided that maintaining a dedicated internal co-manufacturing operation is no longer necessary to support the Company’s commercialization strategy and is accordingly winding down its REVworx co-manufacturing operations.

The wind-down is expected to materially reduce facility, labour, and other operating costs. Once fully implemented, the broader restructuring is expected to reduce EnWave’s annual operating expense structure by approximately $1M and materially improving net income, assuming other operating factors remain unchanged. With this operating expense reduction, the Company’s total operating expense base should lower to approximately $3.7M by fiscal 2028. These cost savings and positive net income impacts are projected to be realized gradually throughout fiscal 2027 with full run-rate impacts realized beginning in fiscal 2028.

EnWave also believes its annualized base royalty collections could reach approximately $3M by the end of fiscal 2027, largely covering the Company’s pro forma base operating costs.

Further, EnWave possesses property, plant and equipment associated with REVworx, including a 10kW REV machine and 60kW REV machine.  The Company estimates the market value of these assets to be approximately $2M, while the IFRS book value is diminutive.

Preserving Innovation and Commercialization Capabilities

EnWave will retain the critical technical infrastructure, personnel, and capabilities required to continue advancing REV technology, conducting product development, and supporting prospective and existing royalty partners.

The Company remains highly active in product innovation, process development, customer demonstrations, and commercial trials by continuing to provide prospective partners with the technical expertise required to validate REV applications and establish commercially viable processing protocols.

Separating these high-value innovation activities from the higher fixed-cost structure associated with commercial co-manufacturing will allow EnWave to operate a more efficient platform while relying on the global platform of already deployed REV equipment to strengthen its ability to develop new applications and support the growth of its existing royalty partner network.

Leveraging EnWave’s Global REV Ecosystem

EnWave has established an extensive international network of 52 licensed royalty partners, several of which possess large-scale, commercial REV production capacity and offer third-party co-manufacturing services.

EnWave has been actively leveraging this ecosystem to connect larger consumer packaged goods (“CPG”) companies and emerging food brands with qualified REV processors where outsourced manufacturing is required. Going forward, this effort will be amplified. This approach provides prospective customers with access to commercial-scale REV capacity.

Sales Pipeline Outlook

EnWave remains highly optimistic about the quality and potential of its commercial sales pipeline. The Company is advancing multiple opportunities with large, well-capitalized food companies across several product categories and geographies, including organizations evaluating REV as a commercial alternative to incumbent dehydration technologies. Importantly, EnWave’s pipeline is increasingly focused on opportunities with clearly defined commercial applications, meaningful production requirements and the potential to generate both equipment revenue and long-term recurring royalties. Recent commercial activity, including the purchase of a second 120kW REV system by Procescir, provides further validation of the economic value of REV at commercial scale and demonstrates the potential for successful royalty partners to expand their installed capacity over time.

Looking ahead to fiscal 2027, management believes the combination of prospective new customers and expansion opportunities within EnWave’s existing royalty partner network provides a compelling foundation for renewed equipment sales growth. Several material opportunities are progressing through the sales cycle, while existing partners are evaluating additional production capacity as demand for REV-dried products expands. Although the timing of large-scale equipment orders will inherently remain uneven, management believes the quality, scale and commercial maturity of the current pipeline are stronger than witnessed to-date by the Company.

About EnWave

EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Delta, BC, EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV) technology, and transformed an innovative idea into a proven, consistent, and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality, and cost.

With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

EnWave’s strategy is to sign royalty-bearing commercial licenses with food producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits of producing exciting new products, reaching optimal moisture levels up to seven times faster, and improve product taste, texture, color and nutritional value.

Learn more at EnWave.net

EnWave Corporation

Mr. Brent Charleton, CFA

President and CEO

For further information:

Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
E-mail: bcharleton@enwave.net      

Nav Dhami, CPA, CFO at +1 (604) 260-4854 
E-mail: ndhami@enwave.net 

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third-party claims referred to in this release are not guaranteed to be accurate. All third-party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The post EnWave Announces Plan to Drive Profitability and Cash Flow Through Streamlined Operations appeared first on EnWave.

“For sixty years, the snack industry operated on three unavoidable inputs: refined flour, added oil, and heat. Loovies Styx is the first industrial snack produced without any of them — made possible by EnWave’s REV vacuum-microwave technology. Classified as NOVA 1 and recognized as one of the healthiest mass-produced snacks in the world by independent European scientific studies, Loovies Styx does not just improve the category. It opens a new one.”

— Héctor M. Sánchez, Founder and CEO, Loovies LLC

A singular serving of Loovies Styx® snack products contain the nutrition equivalent to 150 grams of fresh vegetables, only has 75kcal and contains zero additives and flours.

EnWave’s REV technology enables snack and ingredient manufacturers to produce nutrient-rich, healthy and delicious products in a quick, economical process. Controlled processing temperatures and fast dehydration, proven at scale by multiple licensed partners, creates value for users of REV machinery. EnWave currently has 52 licenses granted globally throughout 24 countries to produce snacks and ingredients comprised of meat, seafood, fruit, vegetable, dairy, confectionary, baked good and cannabis products.

About Loovies LLC

Loovies is an emerging food technology company focused on developing innovative, better-for-you snacks made from whole fruits and vegetables. The company’s flagship Loovies Styx product is a plant-based crunchy snack formulated without refined flour, added oils, preservatives or artificial colours and is free from gluten, soy, dairy, corn and wheat. Independent nutritional and regulatory analysis across more than 40 international markets found that Loovies Styx did not trigger warning-label thresholds under the systems evaluated and highlighted its high dietary fibre and very low saturated fat profile.

With a mission to combine nutrition, convenience and great-tasting snack experiences, Loovies is positioning its platform to address growing consumer demand for cleaner-label, minimally processed alternatives to conventional snacks. The Loovies brand encompasses dehydrated and freeze-dried fruits and vegetables, fruit-based snacks and vegetable-based snack foods, supporting the company’s broader ambition to establish a differentiated presence in the global healthy-snacking category.

For more information, please visit https://loovies.co/.

About EnWave

EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Delta, BC, EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV) technology, and transformed an innovative idea into a proven, consistent, and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality, and cost.

With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

EnWave’s strategy is to sign royalty-bearing commercial licenses with food producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits of producing exciting new products, reaching optimal moisture levels up to seven times faster, and improve product taste, texture, color and nutritional value.

Learn more at EnWave.net

EnWave Corporation

Mr. Brent Charleton, CFA

President and CEO

For further information:

Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
E-mail: bcharleton@enwave.net      

Nav Dhami, CPA, CFO at +1 (604) 260-4854 
E-mail: ndhami@enwave.net 

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third-party claims referred to in this release are not guaranteed to be accurate. All third-party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The post EnWave Announces Healthy Snack Launch of Loovies LLC, a Previously Unnamed Royalty Partner appeared first on EnWave.

All values in thousands and denoted in CAD unless otherwise stated.

• Reported Q3 2026 revenue of $3,313 an increase of $569 compared to the same period in the prior year. The increase was primarily driven by the sale of a large- scale machine that had been fully fabricated and held in inventory in prior periods and higher royalties.
• Reported royalties, excluding exclusivity payments (“Base Royalties”), for Q3 2026 of $536, an increase of $104, or 24% relative to the comparable period in the prior year. Royalties increased due to higher product sales and partner production for the quarter.
• Gross margin for the three months ended Q3 2026 was 25% compared to 19% for the three months ended Q3 2025. The increase in margin was primarily attributable to lower fabrication costs resulting from fewer large-scale machines on contract as compared to the prior quarter.
• Reported a decrease in Selling, General & Administrative (“SG&A”) costs (including Research & Development (“R&D”)) of $205 for Q3 2026 relative to the comparable period in the prior year, with the decrease primarily related to lower personnel and third-party commission costs offset by higher professional development fees and tradeshow attendance.
• Reported an Adjusted EBITDA⁽¹⁾ loss of $93 for Q3 2026, a $482 improvement from the prior year, driven by large-scale equipment sale and lower SG&A expenses, including R&D.

Consolidated Financial Performance:

Note: ⁽¹⁾ Adjusted EBITDA is a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures disclosure below for a reconciliation to the nearest IFRS equivalent.

EnWave’s consolidated interim financial statements and MD&A are available on SEDAR+ at www.sedarplus.ca and on the Company’s website www.enwave.net

Key Financial Highlights for the Nine Months Ended June 30, 2026 (expressed in 000’s)

• Reported revenue of $6,072 a decrease of $1,538 relative to the comparable period in the prior year. The decrease was primarily related to fewer machine sales.  
• Reported Base Royalties of $1,470, an increase of $139 or 10% relative to the comparative period in the prior year. Reported total royalty revenues of $1,628, an increase of $163 or 10% relative to the comparative period in the prior year. Royalties grew due to increased royalty partners, product sales, partner production, and exclusivity payments.
• Reported a $73 increase in SG&A costs for the nine months ended June 30, 2026, primarily due to higher sales personnel, patent maintenance, legal fees associated with general business activities, and recruitment costs. Prior-year financing-related legal costs were capitalized as part of the transaction.
• Reported an Adjusted EBITDA⁽¹⁾ loss of $1,453 for the nine months ended June 30, 2026, a decrease of $355 from the comparable period in the prior year.

Significant Corporate Accomplishments in Q3 2026 and Subsequently:

• Signed an Equipment Purchase Agreement with Procescir S.A. de C.V. for the purchase of second 120kW REVTM machine.
• Signed a Technology Evaluation and License Option Agreement with Swiss Cannabis Selection AG.
• Signed a Technology Evaluation and License Option Agreement with one of the world’s largest multinational food companies.
• Signed a Commercial Licence Agreement and Equipment Purchase Agreement for a 10kW REVTM machine with The Dry Hub (“DryHub”), an Egyptian food processing Company.
• Signed a Research and Development License Agreement with Rhizome Food and Farming LLC (“Rhizome”), a North American food Company led by renowned chef Dan Barber. Rhizome acquired a 3.6kW REVTM machine for commercial and product development.
• Subsequent to the quarter, the Company signed Research and Development License Agreement with the University of Limerick (“Limerick”) in Ireland. Limerick acquired a small-scale REVTM machine to support research and product development.

Non-IFRS Financial Measures:

This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery, non-recurring income and expenses,  restructuring and severance charges, and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated interim financial statements.

Non-IFRS financial measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management. Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on SEDAR+ www.sedarplus.ca.

About EnWave

EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Delta, BC, EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV) technology, and transformed an innovative idea into a proven, consistent, and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality, and cost.

With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

EnWave’s strategy is to sign royalty-bearing commercial licenses with food producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits of producing exciting new products, reaching optimal moisture levels up to seven times faster, and improve product taste, texture, color and nutritional value.

Learn more at EnWave.net.

EnWave Corporation

Mr. Brent Charleton, CFA

President and CEO

For further information:

Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
E-mail: bcharleton@enwave.net      

Nav Dhami, CPA, CFO at +1 (604) 260-4854 
E-mail: ndhami@enwave.net 

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third-party claims referred to in this release are not guaranteed to be accurate. All third-party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The post EnWave 2026 Third Quarter Consolidated Interim Financial Results appeared first on EnWave.

The Company has scheduled a conference call to discuss the results for Q3 2026 and business outlook on Friday, August 21, 2026 at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time). Brent Charleton, Chief Executive Officer and Nav Dhami, Chief Financial Officer will present EnWave’s results and host a question and answer period.

Conference Call Details:

About EnWave

EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Delta, BC, EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV) technology, and transformed an innovative idea into a proven, consistent, and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality, and cost.

With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

EnWave’s strategy is to sign royalty-bearing commercial licenses with food producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits of producing exciting new products, reaching optimal moisture levels up to seven times faster, and improve product taste, texture, color and nutritional value.

Learn more at EnWave.net.

EnWave Corporation

Mr. Brent Charleton, CFA

President and CEO

For further information:

Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
E-mail: bcharleton@enwave.net      

Nav Dhami, CPA, CFO at +1 (604) 260-4854
E-mail: ndhami@enwave.net  

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information concerning the completion of the Offering, the use of proceeds of the Offering, the approval of the TSXV, the growth of the Company’s production capacity and the effects thereof, and the management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing or statements that include words such as “may”, “will”, “plan”, “expect”, “anticipate”, “estimate”, “intend” and similar words are forward-looking statements. These statements are based on the current opinions and expectations of management and are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially as described in more detail in the Company’s recent securities filings available at www.sedarplus.ca, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company does not intend, and disclaims any obligation, except as required by applicable laws, to update or revise any forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The post EnWave to Report Third Quarter Financial Results on August 20, 2026 and Host Investor Conference Call appeared first on EnWave.

Under the Agreement, Limerick will establish REV capabilities to provide researchers and industry participants with direct access to REV technology for product development, process optimization and applied research.

The establishment of accessible REV research and development hubs is an important component of EnWave’s strategy to accelerate the adoption of its technology. These hubs provide prospective commercial partners with a lower-risk and capital-efficient pathway to evaluate REV technology, develop new products and validate processing parameters prior to considering larger-scale commercial deployment. The Company intends to continue pursuing relationships with universities, research organizations, food innovation centres and other qualified partners that can broaden access to REV technology.

By placing REV equipment within established research and innovation ecosystems, EnWave can expand the number of companies engaging with its technology while supporting a broader pipeline of potential commercial opportunities. EnWave has developed a growing global network of REV installations spanning commercial processors, research institutions and innovation centres, with hubs now operational in Denmark, Spain, Ireland, Germany, the US, Australia and Canada.

EnWave sees significant value in expanding independent academic research involving REV. Peer-reviewed studies can provide additional third-party validation regarding product quality, processing efficiency, nutrient retention and other potential advantages of REV compared to conventional drying technologies. Building a deeper body of independent scientific evidence further strengthens the value proposition supporting EnWave’s commercial efforts. EnWave’s strategy remains focused on expanding its global installed base of REV machinery, growing recurring royalty revenue and developing a larger pipeline of commercial opportunities through increased industry engagement with its proprietary technology.

About University of Limerick

The University of Limerick (“UL”) is a leading public research university located in Limerick, Ireland, recognized for its strong focus on innovation, industry collaboration and applied research. UL conducts multidisciplinary research across food science, engineering, materials, health and other fields, working closely with industry partners to translate academic research into commercially relevant technologies and solutions. For more information on UL, please visit https://www.ul.ie/.

For further information:

Farhad Garavand, Associate Professor in Food Science

E-mail: Farhad.Garavand@ul.ie  

About EnWave

EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Delta, BC, EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV) technology, and transformed an innovative idea into a proven, consistent, and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality, and cost.

With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

EnWave’s strategy is to sign royalty-bearing commercial licenses with food producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits of producing exciting new products, reaching optimal moisture levels up to seven times faster, and improve product taste, texture, color and nutritional value.

Learn more at EnWave.net

EnWave Corporation

Mr. Brent Charleton, CFA

President and CEO

For further information:

Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
E-mail: bcharleton@enwave.net      

Nav Dhami, CPA, CFO at +1 (604) 260-4854 
E-mail: ndhami@enwave.net 

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third-party claims referred to in this release are not guaranteed to be accurate. All third-party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The post EnWave Signs Research and Development License Agreement, Sells Radiant Energy Vacuum Machine to University of Limerick, Ireland appeared first on EnWave.

The acquisition of a second large-scale REV system reflects the successful commercialization of Procescir’s first production line and growing demand for premium REV-dried fruit, vegetable and ingredient products. Once commissioned, the additional machinery will substantially increase Procescir’s manufacturing capacity, enabling the company to expand production for both private-label and branded products while supporting its growing toll drying business serving international food companies.

Procescir, a vertically integrated Mexican agricultural company with decades of farming and food processing expertise, has rapidly established itself as one of EnWave’s flagship commercial partners in Latin America. The second 120kW REV machine reinforces Procescir’s long-term commitment to REV technology and positions the company to capitalize on increasing demand for high-quality, nutritious dried ingredients and snacks across North America. The purchase further strengthens EnWave’s growing royalty portfolio, as the additional production capacity is expected to translate into higher recurring royalty revenue as commercial production ramps. EnWave expects to deliver this second 120kW machine to Procescir’s facility within the 2026 calendar year.

Chief Financial Officer Transition

The Company also announced that Ms. Nav Dhami has been appointed as Chief Financial Officer (CFO), effective July 24, 2026.  Ms. Dhami will be replacing Mr. Dylan Murray, the current CFO, who has accepted another professional opportunity. The Company would like to thank Mr. Murray for his 4 years of financial leadership at the Company and for his many contributions over the years.

Ms. Dhami brings over ten years of progressive financial leadership to the Company and currently serves as EnWave’s Financial Controller.  She has extensive experience in the areas of financial operations, risk management and financial reporting.  Ms. Dhami is joining an EnWave executive team that is committed to accelerating growth and forging a path to sustained profitability to create shareholder value. The Company has granted Ms. Dhami an aggregate of 300,000 incentive stock options, subject to the terms of the Company’s Stock Option Plan (the “Plan”), that are exercisable at the last closing price of the Company’s common shares on the TSX Venture Exchange (“TSXV”) on July 24^th, 2026. The incentive stock options are exercisable for a term of five years and will vest in one-third increments over eighteen months in accordance with the provisions set out in the Plan, or as otherwise required by the TSXV. The grant of the equity incentive stock options is subject to approval by the TSXV.

About Procescir

Procescir is a vertically integrated agro-industrial company, with farming operations in Northwest Mexico since 1960. They began commercializing frozen vegetables in 2022, when they started production at their newest processing plant in Hermosillo, Sonora. Procescir’s processes comply with the highest standards in Quality and Food Safety, delivering the best products to their customers.

For more information about Procescir, please visit https://procescir.com/.

About EnWave

EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Delta, BC, EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV) technology, and transformed an innovative idea into a proven, consistent, and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality, and cost.

With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

EnWave’s strategy is to sign royalty-bearing commercial licenses with food producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits of producing exciting new products, reaching optimal moisture levels up to seven times faster, and improve product taste, texture, color and nutritional value.

Learn more at EnWave.net

EnWave Corporation

Mr. Brent Charleton, CFA

President and CEO

For further information:

Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
E-mail: bcharleton@enwave.net      

Dylan Murray, CPA, CA, CFO at +1 (778) 870-0729
E-mail: dmurray@enwave.net  

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third-party claims referred to in this release are not guaranteed to be accurate. All third-party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The post EnWave Sells 120kW Radiant Energy Vacuum Machine to Procescir S.A. de C.V.; Announces Chief Financial Officer Transition appeared first on EnWave.

Under the terms of the Agreement, SCS, in collaboration with Schibano, will conduct a comprehensive evaluation of EnWave’s proprietary Radiant Energy Vacuum (“REV”) dehydration technology for potential application across a range of cannabinoid and botanical products. Upon successful completion of the evaluation program, SCS will have the option to enter into a commercial license agreement granting certain rights to deploy REV technology within agreed-upon markets and applications.

The Agreement follows a series of recent commercial-scale evaluations of REV technology that demonstrated the ability to accelerate drying timelines while maintaining key product quality characteristics. Independent testing conducted across multiple cannabis cultivars showed no statistically significant differences in sensory quality compared to conventionally dried control samples, no meaningful impact on cannabinoid potency, no material change in total yeast and mold counts, and generally stable terpene profiles. The evaluations also demonstrated the potential to reduce overall drying time by approximately two to five days, creating opportunities for increased production throughput and reduced dry-room occupancy.

SCS is collaborating with Schibano on the evaluation program. SCS operates an advanced indoor cannabis cultivation facility and focuses on the production of high quality medical cannabis under ecological standards and GACP compliant practices. Schibano operates a vertically integrated “Seed-to-Pharma” platform encompassing genetics development, cultivation, extraction, active pharmaceutical ingredient manufacturing and finished product production. It maintains pharmaceutical-quality manufacturing standards and serves customers across international markets. Together, the companies bring complementary expertise spanning cannabis cultivation, pharmaceutical development and cannabinoid product manufacturing.

The evaluation will focus on assessing REV technology’s ability to process cannabinoid and botanical materials efficiently while preserving critical quality attributes and meeting the operational and regulatory requirements of SCS and Schibano. Evaluation activities are expected to commence in the coming months.

About Swiss Cannabis Selection AG

SCS Swiss Cannabis Selection AG is a Switzerland based medical cannabis company specializing in the cultivation, development and production of cannabis and cannabis products for medical purposes. The company operates an advanced indoor cultivation facility in the St. Gallen Rhine Valley and produces high quality Swiss cannabis under ecological standards and GACP compliant practices. Through its cultivation expertise and focus on quality, SCS supports the development of cannabis products for medicinal and regulated markets. SCS’s advanced cultivation capabilities and commitment to producing high quality medical cannabis position the company among the emerging innovators helping shape Switzerland’s rapidly evolving medical cannabis sector. For more information on SCS, please visit https://cannabis-selection.ch/.

About Schibano Pharma AG

Schibano Pharma AG is a Switzerland-based life sciences and phytopharmaceutical company specializing in cannabinoid-derived active pharmaceutical ingredients, medicinal products and medical wellness solutions. Through its proprietary “Seed-to-Pharma” platform, the company integrates research and development, genetics, cultivation, pharmaceutical manufacturing and regulatory expertise to deliver high-quality cannabinoid products to pharmaceutical, clinical and commercial markets. Schibano Pharma’s GMP-certified operations and longstanding focus on cannabinoid innovation position the company among the early pioneers in the development of pharmaceutical-grade cannabinoid solutions in Europe. For more information on Schibano, please visit https://schibano-swiss-pharma.com/en/.

About EnWave

EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Delta, BC, EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV) technology, and transformed an innovative idea into a proven, consistent, and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality, and cost.

With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

EnWave’s strategy is to sign royalty-bearing commercial licenses with food producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits of producing exciting new products, reaching optimal moisture levels up to seven times faster, and improve product taste, texture, color and nutritional value.

Learn more at EnWave.net

EnWave Corporation

Mr. Brent Charleton, CFA

President and CEO

For further information:

Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
E-mail: bcharleton@enwave.net      

Dylan Murray, CPA, CA, CFO at +1 (778) 870-0729
E-mail: dmurray@enwave.net  

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third-party claims referred to in this release are not guaranteed to be accurate. All third-party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The post EnWave Signs Technology Evaluation and License Option Agreement with Swiss Cannabis Selection AG, Announces Significant Evaluation Results appeared first on EnWave.

All values in thousands and denoted in CAD unless otherwise stated.

• Reported revenue for Q2 2026 of $1,159, representing a decrease of $2,530 relative to the comparable period in the prior year. The decrease was primarily related to fewer machine sales and machines in fabrication due to the inherent volatility in large-scale Radiant Energy Vacuum (“REV”) machine orders.
• Reported royalties, excluding exclusivity payments (“Base Royalties”), for Q2 2026 of $434, a decrease of $40, or 8% relative to the comparable period in the prior year.  Reported total royalty revenue for Q2 2026 of $465, a decrease of $9 or 2% relative to total royalty revenue in the comparable period in the prior year. Royalties decreased due to lower product sales and partner production for the quarter. The Company expects royalty revenue growth in future periods as a few partners have communicated inventory builds in anticipation of increased commercial sales activity and expanded product distribution in upcoming quarters.
• Gross margin for the three months ended Q2 2026 was 35% compared to 33% for the three months ended Q2 2025. The increase in margin was primarily attributable to lower fabrication costs from large-scale machines on contract, as compared to the prior quarter.
• Reported an increase in Selling, General & Administrative (“SG&A”) costs (including Research & Development (“R&D”)) of $78 for Q2 2026 relative to the comparable period in the prior year, with the increase primarily related to more sales personnel, the timing of patent maintenance fees and professional fees.
• Reported an Adjusted EBITDA⁽¹⁾ loss of $775 for Q2 2026, a decrease of $887 from the comparable period in the prior year.

Consolidated Financial Performance:

Note: ⁽¹⁾ Adjusted EBITDA is a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures disclosure below for a reconciliation to the nearest IFRS equivalent.

EnWave’s consolidated interim financial statements and MD&A are available on SEDAR+ at www.sedarplus.ca and on the Company’s website www.enwave.net

Key Financial Highlights for the Six Months Ended March 31, 2026 (expressed in 000’s)

• Reported revenue of $2,759, a decrease of $2,107 relative to the comparable period in the prior year. The decrease was primarily related to fewer machine sales. 
• Reported Base Royalties of $934, an increase of $35 or 4% relative to the comparative period in the prior year. Reported total royalty revenues of $1,092, an increase of $59 or 5% relative to the comparative period in the prior year. Royalties grew due to increased royalty partners, product sales, partner production, and exclusivity payments.
• Reported an increase in SG&A costs of $278 for the six months ending March 31, 2026, relative to the comparable period in the prior year, with the increase primarily related to more sales personnel, patent maintenance fees, and recruitment fees. In the comparative period, legal costs associated with the Term Loan and Credit Facility were capitalized as part of the transaction.
• Reported an Adjusted EBITDA⁽¹⁾ loss of $1,360 for the six months ended March 31, 2026, a decrease of $837 from the comparable period in the prior year.

Significant Corporate Accomplishments in Q2 2026 and Subsequently:

• Signed a Technology Evaluation and License Option Agreement with one of the world’s largest multinational food companies. 
• Signed a Commercial Licence Agreement (“CLA”) and Equipment Purchase Agreement (“EPA”) for a 10kW REV^TM machine  with The Dry Hub (“DryHub”), an Egyptian food processing Company.
• Signed a Research and Development License Agreement (“RDLA”) with Rhizome Food and Farming LLC (“Rhizome”), a North American food Company led by renowned chef Dan Barber. Rhizome acquired a 3.6kW REV^TM machine for commercial and product development.
• Signed a RDLA and EPA for a 10kW REV^TM machine with Teagasc, the Agriculture and Food Development Authority of Ireland.
• Signed a CLA with Gowen Gumlu Grower’s Association (“BGGA”) in North Queensland, Australia. BGGA acquired a 10kW REV machine from EnWave’s Australian third-party machine re-seller, Scitek.

Non-IFRS Financial Measures:

This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery, non-recurring income and expenses,  restructuring and severance charges, and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated interim financial statements.

Non-IFRS financial measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management. Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on SEDAR+ www.sedarplus.ca.

About EnWave

EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Delta, BC, EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV) technology, and transformed an innovative idea into a proven, consistent, and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality, and cost.

With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

EnWave’s strategy is to sign royalty-bearing commercial licenses with food producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits of producing exciting new products, reaching optimal moisture levels up to seven times faster, and improve product taste, texture, color and nutritional value.

Learn more at EnWave.net.

EnWave Corporation

Mr. Brent Charleton, CFA

President and CEO

For further information:

Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
E-mail: bcharleton@enwave.net      

Dylan Murray, CPA, CA, CFO at +1 (778) 870-0729
E-mail: dmurray@enwave.net  

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third-party claims referred to in this release are not guaranteed to be accurate. All third-party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The post EnWave 2026 Second Quarter Consolidated Interim Financial Results appeared first on EnWave.

Under the terms of the Agreement, the Partner will conduct a commercial-scale evaluation of EnWave’s proprietary Radiant Energy Vacuum (“REV”) dehydration technology for potential application across multiple food categories within the Partner’s extensive global product portfolio. Subject to successful completion of the evaluation program, the Agreement provides the Partner with the option to negotiate one or more commercial royalty-bearing licenses for the use of REV technology.

The Partner is a global leader in branded consumer foods with annual revenues exceeding US$20 billion and operations spanning retail grocery, snack foods, breakfast cereals, frozen foods, convenience meals, and ingredient solutions. The Partner distributes products in more than 100 countries and maintains a portfolio of internationally recognized household brands.

This Agreement represents another meaningful validation of REV technology by a highly sophisticated multinational food manufacturer. Global consumer packaged food companies continue to seek differentiated manufacturing technologies that can improve product quality, optimize operational efficiency, and support innovation across large-scale product platforms.

The evaluation program will focus on assessing REV’s ability to preserve flavor, texture, color, and nutritional characteristics while reducing drying times compared to conventional dehydration methods. The Partner is also expected to evaluate REV’s potential to support premium product innovation and manufacturing efficiencies across select high-volume product categories.

EnWave believes the Agreement further demonstrates growing interest in REV technology from multinational food manufacturers seeking advanced processing solutions capable of supporting evolving consumer preferences for premium, minimally processed, and high-quality shelf-stable products.

The Company expects the evaluation work to commence over the coming months at the Partner’s facilities and at EnWave’s innovation center in Vancouver, Canada.

About EnWave

EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Delta, BC, EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV) technology, and transformed an innovative idea into a proven, consistent, and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality, and cost.

With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

EnWave’s strategy is to sign royalty-bearing commercial licenses with food producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits of producing exciting new products, reaching optimal moisture levels up to seven times faster, and improve product taste, texture, color and nutritional value.

Learn more at EnWave.net

EnWave Corporation

Mr. Brent Charleton, CFA

President and CEO

For further information:

Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
E-mail: bcharleton@enwave.net      

Dylan Murray, CPA, CA, CFO at +1 (778) 870-0729
E-mail: dmurray@enwave.net  

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third-party claims referred to in this release are not guaranteed to be accurate. All third-party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The post EnWave Signs Technology Evaluation and License Option Agreement with Leading Global Packaged Food Company appeared first on EnWave.

The Company has scheduled a conference call to discuss the results for Q2 2026 and business outlook on Friday, May 22, 2026 at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time). Brent Charleton, Chief Executive Officer and Dylan Murray, Chief Financial Officer will present EnWave’s results and host a question and answer period.

Conference Call Details:

About EnWave

EnWave is a global leader in the innovation and application of vacuum microwave dehydration. From its headquarters in Delta, BC, EnWave has developed a robust intellectual property portfolio, perfected its Radiant Energy Vacuum (REV) technology, and transformed an innovative idea into a proven, consistent, and scalable drying solution for the food, pharmaceutical and cannabis industries that vastly outperforms traditional drying methods in efficiency, capacity, product quality, and cost.

With more than fifty partners spanning twenty-four countries and five continents, EnWave’s licensed partners are creating profitable, never-before-seen snacks and ingredients, improving the quality and consistency of their existing offerings, running leaner and getting to market faster with the company’s patented technology, licensed machinery, and expert guidance.

EnWave’s strategy is to sign royalty-bearing commercial licenses with food producers who want to dry better, faster and more economical than freeze drying, rack drying and air drying, and enjoy the following benefits of producing exciting new products, reaching optimal moisture levels up to seven times faster, and improve product taste, texture, color and nutritional value.

Learn more at EnWave.net.

EnWave Corporation

Mr. Brent Charleton, CFA

President and CEO

For further information:

Brent Charleton, CFA, President and CEO at +1 (778) 378-9616
E-mail: bcharleton@enwave.net      

Dylan Murray, CPA, CA, CFO at +1 (778) 870-0729
E-mail: dmurray@enwave.net  

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information concerning the completion of the Offering, the use of proceeds of the Offering, the approval of the TSXV, the growth of the Company’s production capacity and the effects thereof, and the management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing or statements that include words such as “may”, “will”, “plan”, “expect”, “anticipate”, “estimate”, “intend” and similar words are forward-looking statements. These statements are based on the current opinions and expectations of management and are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially as described in more detail in the Company’s recent securities filings available at www.sedarplus.ca, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company does not intend, and disclaims any obligation, except as required by applicable laws, to update or revise any forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The post EnWave to Report Second Quarter Financial Results on May 21, 2026 and Host Investor Conference Call appeared first on EnWave.